Clinical inquiries: how does VTE risk for the patch and vaginal ring compare with oral contraceptives?
Elliott
Tricia C
TC
Baylor-Kelsey-Seybold Family Medicine Residency Program, Houston, TX USA.
Montoya
Cathy C
CC
Williams
Richard
R
D000279:Administration, Cutaneous; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000009:adverse effects; D003274:Contraceptive Devices, Female / Q000009:adverse effects*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015994:Incidence; D012307:Risk Factors; D014481:United States / Q000453:epidemiology; D020246:Venous Thrombosis / Q000453:epidemiology / Q000209:etiology*
D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral